Skip to main content
PMC home page
Gut logoLink to Gut
. 1993;34(2 Suppl):S36–S38. doi: 10.1136/gut.34.2_suppl.s36

Problems in diagnosing viral hepatitis.

F Bonino 1, G Colloredo Mels 1, G Bellati 1, G Ideo 1, F Oliveri 1, P Colombatto 1, M R Brunetto 1
PMCID: PMC1374001  PMID: 8314490

Abstract

The most reliable method of making a specific aetiological diagnosis of chronic viral hepatitis would be to identify virus specific cytotoxic T lymphocytes responsible for the killing of virus infected hepatocytes in each patient's liver. Unfortunately, this can not be proposed for routine diagnosis and surrogate tests are required. The detection of virus markers, and even of the virus itself, does not imply that liver damage is caused by virus infection. Indirect markers of the host's antiviral immunoresponse have to be used to confirm more specifically the diagnosis of viral hepatitis. IgM antibodies against viral antigens implicated in the elimination of the virus seem to be suitable alternative candidates. Significant changes in the serum values of viraemia and aminotransferases occur within a few days, while a significant variation in liver histology takes much longer. Only the kinetics of the highly variable parameters can be used for an appropriate study of the relationship between viraemia, antiviral immunoresponse, and liver cell necrosis. Quantitative and dynamic analyses of hepatitis virus markers seem the most suitable and reliable methods of monitoring the patients eligible for antiviral treatment and identifying the most appropriate time to start this.

Full text

PDF
S37

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barany F. Genetic disease detection and DNA amplification using cloned thermostable ligase. Proc Natl Acad Sci U S A. 1991 Jan 1;88(1):189–193. doi: 10.1073/pnas.88.1.189. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Barany F. The ligase chain reaction in a PCR world. PCR Methods Appl. 1991 Aug;1(1):5–16. doi: 10.1101/gr.1.1.5. [DOI] [PubMed] [Google Scholar]
  3. Birkenmeyer L. G., Mushahwar I. K. DNA probe amplification methods. J Virol Methods. 1991 Nov-Dec;35(2):117–126. doi: 10.1016/0166-0934(91)90127-l. [DOI] [PubMed] [Google Scholar]
  4. Bonino F., Hoyer B., Nelson J., Engle R., Verme G., Gerin J. Hepatitis B virus DNA in the sera of HBsAg carriers: a marker of active hepatitis B virus replication in the liver. Hepatology. 1981 Sep-Oct;1(5):386–391. doi: 10.1002/hep.1840010503. [DOI] [PubMed] [Google Scholar]
  5. Bonino F. The importance of hepatitis B viral DNA in serum and liver. J Hepatol. 1986;3(1):136–141. doi: 10.1016/s0168-8278(86)80158-1. [DOI] [PubMed] [Google Scholar]
  6. Brunetto M. R., Oliveri F., Rocca G., Criscuolo D., Chiaberge E., Capalbo M., David E., Verme G., Bonino F. Natural course and response to interferon of chronic hepatitis B accompanied by antibody to hepatitis B e antigen. Hepatology. 1989 Aug;10(2):198–202. doi: 10.1002/hep.1840100213. [DOI] [PubMed] [Google Scholar]
  7. Bréchot C. Polymerase chain reaction. A new tool for the study of viral infections in hepatology. J Hepatol. 1990 Jul;11(1):124–129. doi: 10.1016/0168-8278(90)90282-v. [DOI] [PubMed] [Google Scholar]
  8. Gerlich W. H., Uy A., Lambrecht F., Thomssen R. Cutoff levels of immunoglobulin M antibody against viral core antigen for differentiation of acute, chronic, and past hepatitis B virus infections. J Clin Microbiol. 1986 Aug;24(2):288–293. doi: 10.1128/jcm.24.2.288-293.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Koike K., Iino S., Kurai K., Mitamura K., Endo Y., Oka H. IgM anti-HBc in anti-HBe positive chronic type B hepatitis with acute exacerbations. Hepatology. 1987 May-Jun;7(3):573–576. doi: 10.1002/hep.1840070326. [DOI] [PubMed] [Google Scholar]
  10. Mantero G., Zonaro A., Albertini A., Bertolo P., Primi D. DNA enzyme immunoassay: general method for detecting products of polymerase chain reaction. Clin Chem. 1991 Mar;37(3):422–429. [PubMed] [Google Scholar]
  11. Rizzetto M., Recchia S., Salizzoni M. Liver transplantation in carriers of the HBsAg. J Hepatol. 1991 Jul;13(1):5–7. doi: 10.1016/0168-8278(91)90855-6. [DOI] [PubMed] [Google Scholar]
  12. Tassopoulos N. C., Sjogren M. H., Ticehurst J. R., Engle R. E., Roumeliotou-Karayannis A., Gerin J. L., Purcell R. H., Papaevangelou G. Significance of IgM antibody to hepatitis B core antigen in a Greek population with chronic hepatitis B virus infection. Liver. 1986 Oct;6(5):275–280. doi: 10.1111/j.1600-0676.1986.tb00291.x. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES